Inflammatory bowel disease and the risk of cardiovascular diseases.

La enfermedad inflamatoria intestinal y los riesgos de enfermedad cardiovascular.
Arterioesclerosis Atherosclerosis Cardiovascular diseases Colitis ulcerosa Crohn's disease Enfermedad de Crohn Enfermedad inflamatoria intestinal Enfermedades cardiovasculares Inflammatory bowel disease Ulcerative colitis

Journal

Gastroenterologia y hepatologia
ISSN: 0210-5705
Titre abrégé: Gastroenterol Hepatol
Pays: Spain
ID NLM: 8406671

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 03 09 2020
revised: 11 09 2020
accepted: 24 09 2020
pubmed: 24 11 2020
medline: 5 11 2021
entrez: 23 11 2020
Statut: ppublish

Résumé

Inflammatory bowel disease (IBD) includes both ulcerative colitis and Crohn's disease, which are well recognised as chronic systemic and immune-mediated conditions that frequently involve extraintestinal manifestations. Although comorbidities have long been the subject of research in other chronic inflammatory diseases, this concept is also emerging in IBD. Many pathologies have been linked to IBD, including cardiovascular disease, which is the main cause of death in developed countries. IBD patients are at increased risk of conditions such as early atherosclerosis and myocardial infarction or venous thrombosis and pulmonary thromboembolism. The aim of this review is to make an approximation of the physiopathology of the different manifestations of cardiovascular disease in patients with IBD and how to prevent them.

Identifiants

pubmed: 33223261
pii: S0210-5705(20)30375-7
doi: 10.1016/j.gastrohep.2020.09.002
pii:
doi:

Types de publication

Journal Article Review

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

236-242

Informations de copyright

Copyright © 2020 Elsevier España, S.L.U. All rights reserved.

Auteurs

Paulina Nuñez (P)

Universidad de Chile, Hospital San Juan de Dios, Sección de Gastroenterología, Santiago, Chile.

Sandra García Mateo (S)

Servicio de Aparato Digestivo. Hospital Clínico Universitario «Lozano-Blesa», IIS Aragón, Zaragoza, España.

Rodrigo Quera (R)

Clínica Las Condes, Departamento de Gastroenterología, Programa de Enfermedad Inflamatoria Intestinal, Santiago, Chile.

Fernando Gomollón (F)

Departamento de Medicina, Facultad de Medicina, IIS Aragón, Zaragoza, España. Electronic address: fgomollo@unizar.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH